Clarissa Parker to In Situ Hybridization, Fluorescence
This is a "connection" page, showing publications Clarissa Parker has written about In Situ Hybridization, Fluorescence.
Connection Strength
0.015
-
Combined analysis of molecular and clinical predictors of gefitinib activity in advanced non-small cell lung cancer: epidermal growth factor receptor mutations do not tell the whole story. J Thorac Oncol. 2006 Jan; 1(1):52-60.
Score: 0.015